Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 625.00 | 384.25 | 698.67 | 815.58 | 0.8592 | 0.7437 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 625.00 | 384.25 | 654.67 | 815.58 | 0.8015 | 0.6273 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 625.00 | 384.25 | 499.00 | 815.58 | 0.6126 | 0.2727 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 625.00 | 384.25 | 522.00 | 815.58 | 0.6406 | 0.3260 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 1250.00 | 894.42 | 2182.00 | 2144.92 | 1.0189 | 1.0335 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 1250.00 | 894.42 | 1860.67 | 2144.92 | 0.8683 | 0.7872 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 1250.00 | 894.42 | 2434.00 | 2144.92 | 1.1388 | 1.2275 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 1250.00 | 894.42 | 2044.33 | 2144.92 | 0.9537 | 0.9267 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 1250.00 | 894.42 | 2197.33 | 2144.92 | 1.0176 | 1.0129 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 1250.00 | 894.42 | 1846.33 | 2144.92 | 0.8666 | 0.7918 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 1250.00 | 894.42 | 1785.33 | 2144.92 | 0.8310 | 0.7211 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 1250.00 | 894.42 | 1167.67 | 2144.92 | 0.5441 | 0.2282 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 1250.00 | 894.42 | 1026.67 | 2144.92 | 0.4788 | 0.1089 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 2500.00 | 1955.17 | 4406.00 | 4304.58 | 1.0244 | 1.0443 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 2500.00 | 1955.17 | 4234.00 | 4304.58 | 0.9834 | 0.9704 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 2500.00 | 1955.17 | 4468.00 | 4304.58 | 1.0375 | 1.0646 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 2500.00 | 1955.17 | 4484.00 | 4304.58 | 1.0423 | 1.0753 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 2500.00 | 1955.17 | 4137.00 | 4304.58 | 0.9609 | 0.9308 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 2500.00 | 1955.17 | 4340.33 | 4304.58 | 1.0083 | 1.0143 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 2500.00 | 1955.17 | 3660.67 | 4304.58 | 0.8502 | 0.7327 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 2500.00 | 1955.17 | 2310.00 | 4304.58 | 0.5368 | 0.1572 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 2500.00 | 1955.17 | 2209.67 | 4304.58 | 0.5134 | 0.1134 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 5000.00 | 1743.19 | 6132.00 | 6230.25 | 0.9842 | 0.9827 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 5000.00 | 1743.19 | 5948.33 | 6230.25 | 0.9549 | 0.9504 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 5000.00 | 1743.19 | 6315.33 | 6230.25 | 1.0137 | 1.0148 |